Stine A, Parmar J, Smith A, Cummins Z, Pillalamarri N, Bender R
NPJ Syst Biol Appl. 2025; 11(1):9.
PMID: 39814773
PMC: 11735615.
DOI: 10.1038/s41540-024-00481-y.
Bedathuru D, Rengaswamy M, Channavazzala M, Ray T, Packrisamy P, Kumar R
NPJ Syst Biol Appl. 2024; 10(1):126.
PMID: 39496637
PMC: 11535547.
DOI: 10.1038/s41540-024-00454-1.
Ramasubbu M, Paleja B, Srinivasann A, Maiti R, Kumar R
Indian J Pharmacol. 2024; 56(4):268-276.
PMID: 39250624
PMC: 11483046.
DOI: 10.4103/ijp.ijp_644_23.
Meid A, Scherkl C, Metzner M, Czock D, Seidling H
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204148
PMC: 11357243.
DOI: 10.3390/ph17081041.
Mohanan E, Shen G, Ren S, Fan H, Moua K, Karolak A
Clin Transl Sci. 2024; 17(8):e70014.
PMID: 39162578
PMC: 11334299.
DOI: 10.1111/cts.70014.
Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeutics.
Kirouac D, Zmurchok C, Morris D
NPJ Syst Biol Appl. 2024; 10(1):31.
PMID: 38499572
PMC: 10948391.
DOI: 10.1038/s41540-024-00355-3.
Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development.
Gao W, Liu J, Shtylla B, Venkatakrishnan K, Yin D, Shah M
CPT Pharmacometrics Syst Pharmacol. 2023; 13(5):691-709.
PMID: 37969061
PMC: 11098159.
DOI: 10.1002/psp4.13079.
In Silico Clinical Trials: Is It Possible?.
Arsene S, Pares Y, Tixier E, Granjeon-Noriot S, Martin B, Brueziere L
Methods Mol Biol. 2023; 2716:51-99.
PMID: 37702936
DOI: 10.1007/978-1-0716-3449-3_4.
Empirical methods for the validation of time-to-event mathematical models taking into account uncertainty and variability: application to EGFR + lung adenocarcinoma.
Jacob E, Perrillat-Mercerot A, Palgen J, LHostis A, Ceres N, Boissel J
BMC Bioinformatics. 2023; 24(1):331.
PMID: 37667175
PMC: 10478282.
DOI: 10.1186/s12859-023-05430-w.
QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation.
Matthews R, Hollinshead D, Morrison D, van der Graaf P, Kierzek A
CPT Pharmacometrics Syst Pharmacol. 2023; 12(7):889-903.
PMID: 37452454
PMC: 10349184.
DOI: 10.1002/psp4.12972.
Systems-based digital twins to help characterize clinical dose-response and propose predictive biomarkers in a Phase I study of bispecific antibody, mosunetuzumab, in NHL.
Susilo M, Li C, Gadkar K, Hernandez G, Huw L, Jin J
Clin Transl Sci. 2023; 16(7):1134-1148.
PMID: 36908269
PMC: 10339700.
DOI: 10.1111/cts.13501.
Deconvolution of clinical variance in CAR-T cell pharmacology and response.
Kirouac D, Zmurchok C, Deyati A, Sicherman J, Bond C, Zandstra P
Nat Biotechnol. 2023; 41(11):1606-1617.
PMID: 36849828
PMC: 10635825.
DOI: 10.1038/s41587-023-01687-x.
Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment.
Ji Y, Madrasi K, Knee D, Gruenbaum L, Apgar J, Burke J
CPT Pharmacometrics Syst Pharmacol. 2023; 12(3):413-424.
PMID: 36710369
PMC: 10014051.
DOI: 10.1002/psp4.12925.
Exploring approaches for predictive cancer patient digital twins: Opportunities for collaboration and innovation.
Stahlberg E, Abdel-Rahman M, Aguilar B, Asadpoure A, Beckman R, Borkon L
Front Digit Health. 2022; 4:1007784.
PMID: 36274654
PMC: 9586248.
DOI: 10.3389/fdgth.2022.1007784.
Towards a comprehensive assessment of QSP models: what would it take?.
Androulakis I
J Pharmacokinet Pharmacodyn. 2022; 51(5):521-531.
PMID: 35962928
PMC: 9922790.
DOI: 10.1007/s10928-022-09820-0.
Analysis of cellular kinetic models suggest that physiologically based model parameters may be inherently, practically unidentifiable.
Brown L, Coles M, McConnell M, Ratushny A, Gaffney E
J Pharmacokinet Pharmacodyn. 2022; 49(5):539-556.
PMID: 35933452
PMC: 9508223.
DOI: 10.1007/s10928-022-09819-7.
Integrated systems modeling of severe asthma: Exploration of IL-33/ST2 antagonism.
Gadkar K, Feigelman J, Sukumaran S, Rodrigo M, Staton T, Cai F
CPT Pharmacometrics Syst Pharmacol. 2022; 11(9):1268-1277.
PMID: 35857704
PMC: 9469696.
DOI: 10.1002/psp4.12842.
Mechanistic Models of COVID-19: Insights into Disease Progression, Vaccines, and Therapeutics.
Desikan R, Padmanabhan P, Kierzek A, van der Graaf P
Int J Antimicrob Agents. 2022; 60(1):106606.
PMID: 35588969
PMC: 9110059.
DOI: 10.1016/j.ijantimicag.2022.106606.
Data-driven learning how oncogenic gene expression locally alters heterocellular networks.
Klinke II D, Fernandez A, Deng W, Razazan A, Latifizadeh H, Pirkey A
Nat Commun. 2022; 13(1):1986.
PMID: 35418177
PMC: 9007999.
DOI: 10.1038/s41467-022-29636-3.
Two heads are better than one: current landscape of integrating QSP and machine learning : An ISoP QSP SIG white paper by the working group on the integration of quantitative systems pharmacology and machine learning.
Zhang T, Androulakis I, Bonate P, Cheng L, Helikar T, Parikh J
J Pharmacokinet Pharmacodyn. 2022; 49(1):5-18.
PMID: 35103884
PMC: 8837505.
DOI: 10.1007/s10928-022-09805-z.